Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-21 Sale |
2022-04-25 5:13 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
70,000 | $15.15 | $1,060,701 | 1,245,763 (Direct) |
View |
| 2022-04-18 Sale |
2022-04-20 5:06 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
30,000 | $16.28 | $488,298 | 106,579 (Indirect Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 4:58 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
56,303 | $15.91 | $896,045 | 1,315,763 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-14 4:56 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
12,823 | $15.55 | $199,335 | 201,883 (Direct) |
View |
| 2022-03-10 Sale |
2022-03-14 4:53 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
27,165 | $15.71 | $426,803 | 136,579 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 4:22 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
383 | $12.68 | $4,857 | 87,494 (Indirect Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 4:18 pm |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
1,388 | $12.66 | $17,568 | 172,359 (Direct) |
View |
| 2022-02-09 Sale |
2022-02-11 4:15 pm |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
3,595 | $12.66 | $45,513 | 1,239,387 (Direct) |
View |
| 2021-07-13 Sale |
2021-07-14 5:32 pm |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
2,631 | $16.98 | $44,675 | 147,447 (Direct) |
View |
| 2021-06-03 Sale |
2021-06-04 7:52 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
9,492 | $21.96 | $208,421 | 122,196 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-02 9:49 pm |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
51,914 | $22.01 | $1,142,375 | 144,078 (Direct) |
View |
| 2021-06-01 Sale |
2021-06-02 9:47 pm |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,119 | $22.1 | $996,963 | 131,688 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-02 9:45 pm |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
21,790 | $21.64 | $471,437 | 85,535 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-02 Option Award |
2022-06-06 5:27 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
20,257 | $0 | 47,504 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:27 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
3,356 | $0 | 47,504 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:24 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
20,257 | $0 | 23,613 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:24 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
3,356 | $0 | 23,613 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:21 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
20,257 | $0 | 54,454 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:21 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
3,356 | $0 | 54,454 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:18 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
20,257 | $0 | 39,822 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:18 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
3,356 | $0 | 39,822 (Direct) |
View |
| 2022-06-02 Option Award |
2022-06-06 5:15 pm |
N/A 2032-06-01 |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
20,257 | $0 | 28,051 (Direct) |
View |
| 2022-06-03 Exercise |
2022-06-06 5:15 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
3,356 | $0 | 28,051 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:11 pm |
N/A 2032-02-29 |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
196,800 | $0 | 549,294 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 6:11 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
76,250 | $0 | 549,294 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:08 pm |
N/A 2032-02-29 |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
199,500 | $0 | 481,451 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 6:08 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
42,347 | $0 | 481,451 (Direct) |
View |
| 2022-03-01 Option Award |
2022-03-03 6:04 pm |
N/A 2032-02-29 |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
432,100 | $0 | 1,991,649 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 6:04 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
132,679 | $0 | 1,991,649 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
1,050 | $0 | 87,877 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:46 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ruffo Frank Chief Financial Officer |
3,875 | $0 | 173,747 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 4:43 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Walker Neal President and CEO |
10,800 | $0 | 1,242,982 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-01 4:50 pm |
N/A 2032-01-31 |
Aclaris Therapeutics Inc. | ACRS | Loerop James Chief Business Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-05 4:33 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
45,518 | $0 | 160,214 (Direct) |
View |
| 2021-11-23 Gift |
2021-12-03 4:52 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
5,500 | $0 | 11,209 (Direct) |
View |
| 2021-03-11 Gift |
2021-11-22 4:03 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
7,500 | $0 | 114,696 (Direct) |
View |
| 2021-11-01 Other |
2021-11-03 4:17 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Foresite Capital Management III LLC Foresite Capital Fund III L.P. Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner |
1,963,180 | $0 | 6,628,733 (Indirect) |
View |
| 2021-09-01 Exercise |
2021-09-02 5:39 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
2,333 | $0 | 86,827 (Direct) |
View |
| 2021-09-01 Tax Withholding |
2021-09-02 5:39 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
1,041 | $17.22 | 86,827 (Direct) |
View |
| 2021-07-02 Exercise |
2021-07-07 6:03 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
6,000 | $0 | 156,078 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:12 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | SCHIFF ANDREW N Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:09 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | Reasons Bryan M. Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:07 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | Powell Andrew Kenneth William Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:05 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | Molineaux Christopher P. Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:02 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | MILANO VINCENT Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 8:00 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | Mehra Anand Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 7:57 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | Humphries William D. Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-04 7:55 pm |
N/A 2031-06-02 |
Aclaris Therapeutics Inc. | ACRS | GOWEN MAXINE Director |
15,606 | $0 | 15,606 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 9:49 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Gordon David N. Chief Medical Officer |
87,500 | $0 | 144,078 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 9:47 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Ali-Jackson Kamil Chief Legal Officer |
33,189 | $0 | 131,688 (Direct) |
View |
| 2021-06-01 Exercise |
2021-06-02 9:45 pm |
N/A N/A |
Aclaris Therapeutics Inc. | ACRS | Monahan Joseph Chief Scientific Officer |
50,000 | $0 | 85,535 (Direct) |
View |